Author: Willes Stuart R. Fitzgerald Thomas K. Proud David Haley Nancy J. Bascom Rebecca
Publisher: Taylor & Francis Ltd
ISSN: 1087-2620
Source: Journal of Toxicology and Environmental Health, Vol.53, Iss.3, 1998-02, pp. : 193-209
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Environmental tobacco smoke (ETS) is a significant component of indoor air pollution yet the acute upper respiratory response has not been well studied. The goal of this study was to determine the response of healthy subjects to moderate levels of sidestream tobacco smoke (SS). Twenty-three subjects were challenged on 2 separate days to clean air or SS (2 h, 15 ppm carbon monoxide, at rest) . Subjects completed symptom questionnaires, posterior rhinomanometry, and body plethysmography. Average total and differential cell counts and albumin concentration were determined on nasal lavage samples. The urinary cotinine : creatinine ratio was used as a biomarker of exposure. Following SS exposure, irritant and rhinitis symptoms increased, nasal resistance rose from 4.9 +/- 0.4 to 6.3 +/- 0.6 cm H2 O/L/s and specific airway conductance decreased from 0.14 +/- 0.01 to 0.13 +/- 0.01 cm H2 O-1 s-1. Total cell counts, neutrophils, and albumin were unchanged. An increased nasal congestive response did not correlate with an increased cotinine : creatinine ratio. A history of ETS rhinitis did not predict an increased group response to smoke, but individuals with the largest physiologic and inflammatory response were historically ETS sensitive. In summary, healthy normal subjects demonstrate nasal congestion with exposure to moderate levels of SS without evidence of increased nasal vascular permeability.
Related content
By Bae Soochan Ke Qingen Koh Young Y. Lee Wooseung Choi Jun H. Kang Peter M. Morgan James P.
Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 5, 2010-05 ,pp. :
By Daniel James Cropley Mark Ussher Michael West Robert
Psychopharmacology, Vol. 174, Iss. 3, 2004-07 ,pp. :